Aug 25, 2026 07:40AM
Aug 6, 2026 09:58AM
Aug 6, 2026 07:42AM
Aug 6, 2026 07:00AM
Aug 6, 2026 07:00AM
May 20, 2026 07:04AM
May 20, 2026 07:03AM Immunovant reports mixed trial results for IMVT-1402 in rheumatoid arthritis
May 20, 2026 07:00AM
Feb 6, 2026 07:05AM
Feb 6, 2026 07:00AM
Jan 23, 2026 05:25PM
Nov 10, 2025 07:32AM
Nov 10, 2025 07:00AM
Oct 27, 2025 04:10PM Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
Aug 11, 2025 11:02AM
Aug 11, 2025 07:00AM
May 29, 2025 07:00AM
Jan 3, 2025 08:23AM
Nov 7, 2024 06:30AM
Aug 6, 2024 04:05PM
May 30, 2024 07:41AM Piper Sandler Reiterates Overweight Rating on Immunovant (IMVT)
May 29, 2024 04:01PM
Feb 12, 2024 07:11AM
Feb 12, 2024 07:00AM
Nov 9, 2023 07:37AM
Nov 9, 2023 07:00AM
Aug 10, 2023 07:00AM
May 22, 2023 07:00AM Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2023
Feb 15, 2023 05:52AM
Feb 3, 2023 07:03AM
Feb 3, 2023 07:00AM
Nov 4, 2022 07:05AM
Nov 4, 2022 07:00AM
Nov 4, 2022 07:00AM
Aug 5, 2022 07:00AM Immunovant Reports Financial Results and Recent Business Updates for the Quarter Ended June 30, 2022
Jun 8, 2022 07:01AM
Jun 8, 2022 07:00AM
Jun 6, 2022 04:47PM
Feb 4, 2022 07:00AM
Nov 5, 2021 07:30AM
Aug 9, 2021 06:30AM
Aug 6, 2021 04:22PM Immunovant to Report Financial Results for Quarter Ended June 30, 2021
Jun 1, 2021 07:31AM
Feb 16, 2021 10:29AM
Feb 16, 2021 08:00AM
Nov 12, 2020 08:00AM
Aug 12, 2020 04:01PM
Jun 29, 2020 07:30AM
Feb 14, 2020 07:00AM Immunovant Reports Financial Results for the Quarter and Nine Months Ending December 31, 2019

1,222,633 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All